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Myelin-Associated Glycoprotein
Interacts with the Nogo66 Receptor
to Inhibit Neurite Outgrowth
with the glial scar forming around these regenerated
axons.
To date, three inhibitors of regeneration have been
identified in myelin. These are NogoA (Chen et al., 2000;
GrandPre et al., 2000; Prinjha et al., 2000), an antigen
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Hunter College associated glycoprotein (MAG) (McKerracher et al.,
City University of New York 1994; Mukhopadhyay et al., 1994), and oligodendrocyte-
695 Park Avenue myelin glycoprotein (OMgp), which was recently shown
New York, New York 10021 to inhibit neurite outgrowth in vitro (Wang et al., 2002). All
2 Division of Neuroscience three of these inhibitors are found in a myelin membrane,
Children’s Hospital immediately adjacent to the axon (Baumann and Pham-
Harvard Medical School Dinh, 2001; Mikol et al., 1990; Trapp, 1988; Huber et
Boston, Massachusetts 02115 al., 2002). Therefore, they are in an optimal location
to mediate axon-glia interactions. Unlike the wealth of
information on receptors and signaling cascades of in-
Summary hibitory molecules involved in axonal guidance during
development (Skaper et al., 2001; Tessier-Lavigne and
Myelin inhibitors of axonal regeneration, like Nogo and Goodman, 1996), very little is known about how myelin
MAG, block regrowth after injury to the adult CNS. inhibitors exert their effects. Currently, two events have
While a GPI-linked receptor for Nogo (NgR) has been been associated with signaling by myelin inhibitors. If
identified, MAG’s receptor is unknown. We show that the small GTPase, Rho, is inactivated (Lehmann et al.,
MAG inhibits regeneration by interaction with NgR. 1999) or if neuronal cAMP is elevated (Cai et al., 1999),
Binding of and inhibition by MAG are lost if neuronal inhibition by not only an individual myelin inhibitor, MAG,
GPI-linked proteins are cleaved. Binding of MAG to is blocked, but so also is inhibition by myelin in general.
NgR-expressing cells is GPI dependent and sialic acid
This suggests that there is either a common signaling
independent. Conversely, NgR binds to MAG-express-
pathway for all myelin inhibitors or different pathways
ing cells. MAG, but not a truncated MAG that binds
converge at a point upstream from Rho and cAMP
neurons but does not inhibit regeneration, precipitates
involvement.NgR from NgR-expressing cells, DRG, and cerebellar
Although two distinct inhibitory domains have beenneurons. Importantly, NgR antibody, soluble NgR, or
described for NogoA, the isoform of Nogo expresseddominant-negative NgR each prevent inhibition of
by oligodendrocytes (Chen et al., 2000; Fournier et al.,neurite outgrowth by MAG. Also, MAG and Nogo66
2001), only a single receptor has been identified to datecompete for binding to NgR. These results suggest
(Fournier et al., 2001). This Nogo receptor, NgR, bindsredundancy in myelin inhibitors and indicate therapies
with high affinity to a 66 amino acid, extracellular se-for CNS injuries.
quence, termed Nogo66, that is found in all three Nogo
isoforms (Chen et al., 2000; GrandPre et al., 2000; PrinjhaIntroduction
et al., 2000) and is anchored to the membrane via a
glycosylphosphatidylinositol (GPI) linkage (Fournier etInhibitors of axonal regeneration that are present in my-
al., 2001). Interestingly, OMgp has also been shown toelin are one of a number of factors that prevent recovery
interact with the NgR and to require this interaction forafter injury in the adult mammalian CNS (Qiu et al., 2000;
its inhibitory effects (Wang et al., 2002).Schwab and Bartholdi, 1996). Other factors include a
Here, we show that like Nogo and OMgp, MAG inter-lack of trophic factors and formation of the glial scar,
acts with the NgR receptor to exert its inhibition. MAGwhich is accompanied by the upregulation of mainly
binds specifically and competes with Nogo66 for bind-proteoglycan inhibitors of regeneration (Fitch and Silver,
ing to an NgR-expressing cell line. Conversely, NgR1999). However, immediately after injury and before the
binds specifically to a MAG-expressing cell line. Also,scar has had time to mature, the main obstacle to regen-
MAG precipitates NgR specifically from NgR-expressingeration appears to be inhibitors, both secreted (Tang
CHO cells, cerebellar neurons, and DRG neurons, whileet al., 1997b, 2001) and membrane bound, in myelin.
a truncated, noninhibitory form of MAG that binds neu-Previous work has shown that if mice are immunized
rons in a sialic acid-dependent manner does not. Impor-with myelin before a spinal cord injury is inflicted, regen-
eration occurs (Huang et al., 1999). This implies that if tantly, a soluble form of NgR, an antibody to NgR, or a
inhibitors of regeneration in myelin are neutralized, at dominant-negative NgR each block inhibition of neurite
least immediately after injury, regeneration can occur outgrowth by MAG. These results indicate redundancy
in the inhibitors of regeneration in myelin and point to
NgR as an attractive target for development of possible3 Correspondence: filbin@genectr.hunter.cuny.edu
4 These authors contributed equally to this study. therapies to encourage regeneration after CNS injury.
Neuron
284
Figure 1. Binding of MAG-Fc and Inhibition
of Neurite Outgrowth Requires GPI-Anchored
Neuronal Proteins
(A) Proteins from lysates of NgR-expressing
CHO cells and cerebellar neurons or a prepa-
ration of NgR-AP were separated by PAGE
and transferred to a membrane before being
stained for NgR or AP, as indicated. Arrow
points to NgR and arrowhead points to NgR-
AP. Molecular weight standards are on the
left. CN  cerebellar neuron lysate
(B) Cerebellar neurons (P4) were plated onto
laminin-coated wells and cultured overnight
before NgR antibody (1:1000) (a–c) or MAG-
Fc (25 g/ml) (d–f) were added and incubated
for 2 hr, after which the cultures were fixed
and NgR detected with a secondary antibody
conjugated to rhodamine. MAG-Fc was de-
tected with a MAG monoclonal antibody, fol-
lowed by a R-phycoerthrin-conjugated sec-
ondary antibody. Where indicated, neurons
were treated with PI-PLC for 30 min and then
cultured for 1 hr (b and e) or 8 hr (c and f)
before addition of the NgR antibody or
MAG-Fc.
(C) Cerebellar neurons (P4), either treated ()
or not () with PI-PLC, were plated onto a
substrate of immobilized L1-Fc, and MAG-
Fc (20 g/ml) was added (hatched bars) and
cultured for 4 hr, after which the cultures were
fixed and stained for GAP43. Results are the
number of neurons with neurites, expressed
as a percentage of the control, untreated neu-
rons, in the absence of MAG-Fc (black bars).
The results are the mean of at least four
experiments,  SEM.
Results In contrast, 1 hr after treatment of these neurons with
PI-PLC, the binding of NgR antibody and of MAG-Fc
are greatly reduced. However, 8 hr after PI-PLC treat-Binding and Inhibition of Neurite Outgrowth
by MAG Each Require a GPI-Linked Protein ment, the binding of NgR antibody and MAG-Fc to these
neurons is restored, indicating the replacement of thePreviously, we showed that a soluble, chimeric form of
MAG, MAG-Fc (the extracellular domain of MAG fused GPI-linked proteins within this time (Figure 1B). Since
the GPI-linked proteins are so rapidly replaced, we hadto the Fc portion of human IgG), was able to specifically
precipitate a number of neuronal surface proteins (De to modify the neurite outgrowth assay we routinely use
by reducing culture times from 18–24 hr to 2–6 hr, andBellard and Filbin, 1999). Of these proteins, one of about
80 kDa is approximately the same molecular weight as rather than measuring neurite length, the number of neu-
rons with neurites were counted. Removal of GPI-linkedthe recently cloned Nogo receptor, NgR. Because of
this similarity in size, we wanted to determine if MAG was proteins from cerebellar neurons prevents the inhibition
of neurite extension by MAG-Fc, while the same treat-bringing about its inhibitory effect through an interaction
with this same receptor. As the NgR receptor is a GPI- ment has no effect on the ability of cerebellar neurons
to extend neurites in the absence of MAG-Fc (Figurelinked protein (Fournier et al., 2001), neurons were
treated with phosphatidylinositol-specific phospholi- 1C). The reduced culture time required for this assay
was not suitable for DRG neurons because under controlpase C (PI-PLC) to remove all GPI-linked proteins, and
the ability of MAG to bind and inhibit neurite outgrowth conditions, they failed to extend detectable neurites by
6 hr. However, these results indicate that binding ofwas assessed. We first wanted to ensure that the com-
mercially available NgR antibody did indeed recognize MAG-Fc to neurons and its ability to inhibit neurite out-
growth are dependent on a neuronal GPI-linked protein.the NgR. Figure 1A shows that this antibody recognizes
an 80 kDa protein expressed by NgR-expressing CHO
cells and by cerebellar neurons. In addition, it binds to MAG Binds to NgR in a Sialic
Acid-Independent Mannera recombinant, soluble form of NgR consisting of the
entire extracellular domain fused to alkaline phospha- To determine if the PI-PLC-sensitive binding of MAG to
neurons is attributable to the NgR, the ability of MAG-tase (NgR-AP Mol.Wt. 150 kDa). This same band is rec-
ognized by an antibody to alkaline phosphatase. Fc to bind to NgR-expressing Chinese hamster ovary
(CHO) cells and the ability of a soluble form of NgR, NgR-The NgR antibody was then used to immunostain neu-
rons. Strong binding of both this NgR antibody and AP, to bind to MAG-expressing CHO cells was assessed.
Figure 2Ab shows that MAG-Fc binds to NgR-express-MAG-Fc to cerebellar neurons is observed (Figure 1B).
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Figure 2. MAG Interacts with NgR
(A) Confluent monolayers of CHO cells expressing NgR (b–d) or control CHO cells (a) were incubated with MAG-Fc (20 g/ml) for 2 hr before
being fixed and immunostained for MAG. The monolayer was treated with PI-PLC (c) or with sialidase (d) before addition of MAG-Fc.
(B) Confluent monolayers of MAG-expressing (b) or control (a) CHO cells were incubated with NgR-AP for 2 hr before being fixed and
immunostained for NgR.
(C) NgR-AP binding, at various concentrations, to immobilized MAG-Fc was measured (a). The Kd of NgR-MAG binding was calculated from
bound NgR/free NgR plotted against bound NgR and calculated to be 8 nM (b).
(D) Lysates of NgR-expressing or control CHO cells (a), cerebellar neurons (b), or DRG neurons (c) were precipitated with MAG-Fc, MAG
(d1-3)-Fc, or an anti-flag antibody as indicated. Precipitated proteins were dissociated and separated in a 10% PAGE, transferred to PVDE
membranes, and stained for NgR, using the ECL detection system. For (b) and (c), controls were without MAG-Fc. Arrows indicate NgR.
ing CHO cells. After PI-PLC treatment, this binding is action should block inhibition of axonal extension by
MAG. To block NgR on neurons, a polyclonal NgR anti-lost (Figure 2Ac), and there is no binding of MAG-Fc to
control CHO cells that do not express NgR (Figure 2Aa). body was included in the neurite outgrowth assays with
MAG-expressing CHO cells (Figure 3B) or with MAG-In addition, although MAG is a sialic acid binding protein
(Kelm et al., 1994), the binding of MAG-Fc to NgR CHO Fc (Figure 3C). The NgR antibody blocked inhibition of
neurite outgrowth by MAG for both DRG and cerebellarcells is sialic acid independent as treatment of these
cells with sialidase has no effect on MAG-Fc binding neurons (Figure 3B). The antibodies had no effect on
axonal growth on control CHO cells and a control anti-(Figure 2Ad). In the converse experiment, NgR-AP
bound specifically to MAG-expressing CHO cells and body had no effect on inhibition by MAG (not shown).
The NgR antibody also blocked the inhibition of neuritenot to control CHO cells (Figure 2B). To determine the
affinity of MAG’s interaction with NgR, the binding of outgrowth from DRG neurons by MAG-Fc (Figure 3C).
An alternative approach to blocking the interaction be-NgR-AP, over a range of concentrations, to MAG-
expressing CHO cells (not shown) or to immobilized tween MAG and its neuronal receptor is to include a
MAG-Fc (Tang et al., 1997a) was measured. A Kd of 8 soluble form of the receptor in the cultures (Flanagan
nM was calculated (Figure 2C) using both approaches. and Cheng, 2000). In this way, the soluble receptor will
This value is very similar to the affinities of both Nogo66 compete for MAG binding with the neuronal receptor
(7 nM) and OMgp (5 nM) in binding to NgR. Importantly, and so prevent interaction and, in turn, prevent the signal
consistent with a direct interaction of these two mole- for inhibition from being transduced to the neuron. To
cules, MAG-Fc was able to precipitate NgR from lysates test this possibility, soluble NgR-AP was included in the
of NgR-expressing CHO cells, DRG neurons, or cerebel- cultures. As shown in Figure 3A, NgR-AP blocked the
lar neurons (Figure 2D). NgR was not precipitated from ability of MAG-expressing CHO cells to inhibit neurite
control CHO cells by MAG-Fc, nor from neurons by MAG outgrowth in a dose-dependent manner. The NgR-AP
(d1-3)-Fc, a truncated form of MAG that binds neurons protein had no effect on neurite outgrowth on the control
in a sialic acid-dependent manner but has no effect on CHO cells. Inhibition of neurite outgrowth by MAG-Fc
neurite outgrowth (Tang et al., 1997a) (Figure 2D). can also be blocked by NgR-AP (Figure 3C).
In addition to soluble NgR-AP, inhibition of neurite
outgrowth by MAG was blocked using a dominant-nega-Blocking NgR Prevents Inhibition
of Neurite Outgrowth by MAG tive form of the NgR. The amino-terminal region of NgR
covering both the leucine rich repeats (LRR) and C-ter-If indeed MAG interacts with the NgR to bring about
inhibition of neurite outgrowth, then blocking that inter- minal LRR (LRRCT) domains has been shown to be nec-
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essary for interaction with both OMgp and Nogo66
(Wang et al., 2002). Therefore, we reasoned that the
unique extreme C-terminal region of NgR, which is not
required for ligand binding, might interact with a signal-
ing coreceptor since the GPI-anchored NgR alone would
not be expected to be able to transduce the inhibitory
signal into the interior of responding neurons. Thus, it
is conceivable that overexpression of a truncated NgR
lacking only the extreme C-terminal region (N-NgR), but
still containing the ligand binding LRR and LRRCT do-
mains, would inhibit the function of wild-type NgR in a
dominant-negative manner. As primary neurons proved
to be refractory to transfection, we tested this hypothe-
sis by introducing full-length (FL-NgR) or truncated
forms of NgR, N-NgR, and, as a control, NgR missing
the ligand binding domains (C-NgR) into NG108 cells, a
neuronal cell line that is responsive to both MAG and
myelin (Lehmann et al., 1999; McKerracher et al., 1994).
As shown in Figure 4, immobilized recombinant MAG
inhibited neurite outgrowth from differentiated NG108
cells. In contrast to full-length NgR or C-NgR, N-NgR
overexpression resulted in robust neurite outgrowth of
NG108 cells (Figures 4B and 4C). Expression of this
mutant NgR had no effect on the ability of NG108 cells
to extend processes in the absence of MAG. Together,
these results suggest that the neutralizing effects of the
dominant-negative NgR are specific for MAG.
MAG and Nogo66 Compete for Binding to NgR
If MAG and NogoA interact with the same receptor, the
question becomes whether the interactions are compet-
itive or noncompetitive. To address this issue, the ability
of Nogo66, the extracellular sequence of Nogo that inter-
acts with NgR, to block binding of MAG-Fc to neurons
was assessed. When Nogo66-AP and MAG-Fc were in-
cluded at the same concentration, there was little effect
on MAG-Fc binding to NgR-expressing CHO cells (Fig-
ure 5A). However, when Nogo66-AP was added in a
2-fold molar excess, MAG-Fc binding was greatly re-
duced, indicating direct competition for the same bind-
ing site (Figure 5B). To assess more precisely the
competition of MAG and Nogo66 for NgR, the IC50 (con-
centration of Nogo66 at which binding of MAG is reduced
by 50%) was determined. By measuring MAG-Fc binding
to cerebellar neurons in the presence of increasing con-
centrations of Nogo66, the IC50 was calculated to be
approximately 120 nM (Figure 5C). An IC50 in the nano-Figure 3. Soluble NgR and NgR Antibody Each Block MAG’s Inhibi-
tion of Neurite Outgrowth molar range indicates that Nogo66 effectively displaces
DRG neurons (A–C) or cerebellar (B) neurons were plated on conflu- MAG binding and therefore that the two ligands compete
ent monolayers of MAG-expressing or control CHO cells (A and B) directly for the same receptor.
or onto L1-Fc as a substrate, and MAG-Fc (20 g/ml) was added
(C). Where indicated, the monolayers were incubated with soluble
DiscussionNgR-AP at either 0.37 or 3.7 g/l or NgR antibody (1:100) for 30
min prior to addition of neurons. For MAG-Fc, NgR-AP (3.7 g/l)
or NgR antibody were added simultaneously to MAG-Fc (C). After The results presented here demonstrate that the Nogo
overnight incubation, the cultures were fixed and stained for GAP43 receptor, NgR, which specifically binds the extracellular
and the longest neurite for 180–200 neurons was measured. Results sequence of 66 amino acids common to all Nogo iso-
represent % of control, which for (A) and (B) is neurons on control forms, also binds MAG and is essential for MAG-medi-
CHO cells and for (C) is in the absence of MAG-Fc,  SEM. Results
ated inhibition of neurite outgrowth from a variety ofare from at least three experiments, each in at least duplicate. Black
neurons. Furthermore, although MAG and Nogo66 havebars, neurons grown on control CHO cells; hatched bars, neurons
on MAG-expressing CHO cells; white bars, neurons with soluble no obvious sequence similarities, they compete with
MAG-Fc as indicated. each other for binding to NgR. In addition to Nogo and
MAG, another myelin-specific protein, OMgp, which has
recently been shown to inhibit neurite outgrowth, also
MAG Interacts with the Nogo Receptor
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Figure 4. A Dominant-Negative NgR Blocks
the Inhibitory Activity of MAG
(A) Differentiated NG108 cells expressing full-
length (FL-NgR), N-terminal (dominant-nega-
tive) (N-NgR), or C-terminal (C-NgR) NgR
were plated on either PDL or immobilized
MAG substrates, incubated overnight, and
then stained for GFP. Scale bar: 12 m. (B)
The longest neurite from individual trans-
fected neurons for each condition was mea-
sured for 180–200 neurons. Statistical analy-
sis was done by one-way ANOVA (p 
0.0001). *Star indicates N-NgR-expressing
cells on MAG have significantly longer neu-
rites than cells expressing FL-NgR or C-NgR
on MAG.
interacts with the NgR and competes with Nogo66 for
this receptor in exerting its inhibitory effect (Wang et
al., 2002). Although we have not assessed whether MAG
and OMgp also compete with each other for binding,
given that Nogo66 competes with both MAG and OMgp
for binding to NgR, it seems that OMgp is also likely to
compete with MAG for binding to this receptor. This
competition for binding to the same receptor may ex-
plain the apparent redundancy observed when a single
inhibitory component is blocked in vivo. For example,
after injury in the MAG knockout mouse, there is only
very little, or no, improvement in axonal regeneration in
vivo (Li et al., 1996; Montag et al., 1994). Likewise, in
vivo application of a monoclonal antibody to Nogo, the
IN-1 antibody, after injury, results in only a small percent-
age of regenerating axons (Schnell and Schwab, 1990,
1993). The effects on regeneration of blocking OMgp in
vivo have not yet been reported. However, extrapolating
from the results with MAG and Nogo, the prediction is
that there would be little effect on regeneration in vivo
if only OMgp is blocked. These results are important
because the effects of these three potent inhibitors of
regeneration can be blocked completely, at least in cul-
ture, by blocking a single receptor, NgR. Indeed,Figure 5. Nogo66 Competes with MAG for Binding to NgR
blocking the NgR with an antagonist of Nogo66 bindingConfluent monolayers of CHO cells expressing NgR were incubated
with MAG-Fc (20 g/ml) along with Nogo66-AP at 3.5 g/ml (A) or has been shown to induce more regeneration after injury
7 g/ml (B) for 2 hr before being fixed and immunostained for MAG. (GrandPre et al., 2002) than when Nogo is blocked with
The IC50 for Nogo66-MAG competition for the NgR (C) was deter- IN-1 (Schnell and Schwab, 1990, 1993) or in MAG knock-
mined by measuring binding of fluorescently labeled neurons to out mice. It remains to be determined if an effective
immobilized MAG-Fc in the presence of various concentrations of
antagonist can be developed that allows complete func-Nogo66-AP (5–500 nM). The IC50 was calculated to be 120 nM. Re-
tional recovery. Conceivably, such an antagonist couldsults are the mean of sextuplets and standard errors are less than




From the time it was realized that there were multiple of MAG to neurons is neither necessary nor sufficient
inhibitors of regeneration in myelin (McKerracher et al., for its ability to inhibit axonal regeneration. First, we
1994; Mukhopadhyay et al., 1994), the debate has been show that binding of MAG to NgR-expressing CHO cells
which, if any, of the inhibitors makes the largest contri- is unaffected by removal of sialic acid residues; interac-
bution to the inhibitory effect of myelin. Because all the tion of MAG and NgR does not require sialic acid (Figure
inhibitors identified to date seem to share the same 2A). Second, MAG (d1-3)-Fc, a truncated form of MAG
receptor, and alternative receptors have yet to be de- missing Ig-like domains 4 and 5, which binds to neurons
scribed, the relative contribution which each inhibitor in a sialic acid-dependent manner but has no effect on
makes to the block of regeneration would then depend neurite outgrowth, does not precipitate NgR (Figure 2D).
on (1) the affinity of each inhibitor for the receptor, (2) As clustering of the ganglioside GT1b with antibodies
the relative concentration of each inhibitor in myelin, in the absence of MAG appears to be sufficient to inhibit
and (3) the likelihood of a regenerating axon encoun- neurite outgrowth (Vinson et al., 2001; Vyas et al., 2002),
tering that particular inhibitor. From binding studies, it is possible that this inhibition is completely indepen-
Nogo66 (7 nM), OMgp (5 nM), and MAG (8 nM) all appear dent of MAG. Another study reports that GT1b interac-
to bind NgR with the same affinity. Furthermore, it has tion with p75 transduces the signal for inhibition by MAG
been estimated that MAG represents 1% of total CNS (Yamashita et al., 2002). It is possible that MAG’s ability
myelin proteins (Quarles, 1997) and that OMgp is a rela- to bind gangliosides potentiates its inhibitory effects by
tively minor component (Baumann and Pham-Dinh, clustering signaling molecules, but there is no evidence
2001). The amount of NogoA in myelin, relative to other to suggest that gangliosides are necessary for MAG’s
myelin proteins, has not been reported. Hence, a direct inhibition.
comparison of relative abundance cannot be made at Previous reports that either inactivation of Rho (Leh-
this time. Although all three of these inhibitors have been mann et al., 1999) or elevation of cAMP (Cai et al., 1999;
reported to be present in a myelin membrane in direct Song et al., 1998) can overcome inhibition by myelin in
contact with the axon, the majority of NogoA is intracel- general and encourage regeneration in vivo (Qiu et al.,
lular (Chen et al., 2000; GrandPre et al., 2000; Huber et 2002; Neumann et al., 2002) indicate that there could
al., 2002). It is likely that after injury, and consequential be a convergence in the signaling pathways of all the
disruption of cellular integrity, this intracellular NogoA inhibitors in myelin. Alternatively, Rho and/or cAMP may
would be exposed to the axons attempting regeneration. be dominant contributors to individual signaling path-
This is important not only because it could expose more ways. Although the proteins Nogo66, MAG, and OMgp
of the 66 residue lumenal domains to NgR, but also share no apparent sequence similarities, their ability to
because the N terminus of the molecule would also compete for receptor binding suggests that they may
be exposed and a second inhibitory domain has been share structural similarities. This point cannot be ad-
mapped to the N terminus of NogoA. The N-terminal dressed until the crystal structure of all three proteins
sequence of Nogo, when immobilized, has been shown has been resolved. On the other hand, because the NgR
to inhibit neurite outgrowth (Chen et al., 2000; Fournier is a GPI-linked protein without a transmembrane do-
et al., 2001; Prinjha et al., 2000). Although the identity main, it alone cannot transduce the signal across the
of the receptor for the N-terminal region of NogoA is membrane but requires a signaling partner(s). It seems
still elusive, the fact that the three inhibitory components possible, but we would argue unlikely given the apparent
require a single NgR receptor and that blocking this convergence in signaling, that the transducing partner
receptor completely overcomes inhibition by myelin in in the NgR receptor complex is different for each of
general (GrandPre et al., 2002) suggests, first, that sig- these three inhibitory ligands.
naling through this receptor is the major route whereby It is well established that MAG is a bifunctional mole-
inhibition is transduced to the neuron. Second, these cule in that it promotes axonal growth from young neu-
results point to considerable redundancy of these inhibi-
rons but, with development, the response of these same
tory ligands (Filbin, 1996). Consistent with the observa-
neurons switches to inhibition by MAG (DeBellard et al.,
tions from earlier in vivo studies (Li et al., 1996; Montag
1996; Johnson et al., 1989; Mukhopadhyay et al., 1994;et al., 1994; Schnell and Schwab, 1990, 1993), it seems
Song et al., 1998). A similar switch occurs in response tounlikely, then, that an individual inhibitor will be the major
myelin in general. We have reported that a spontaneouseffector of myelin inhibition.
decrease in the endogenous levels of neuronal cAMP,It is not known if there are other functional receptors
and not a change in the MAG/myelin receptor(s), canfor OMgp and MAG. A number of neuronal and extracel-
account for this switch in response (Cai et al., 2001).lular matrix binding partners have been reported for
Consistent with this suggestion, P1 DRG neurons, whichMAG (Fahrig et al., 1987; Franzen et al., 2001; Yamashita
are promoted by MAG and not inhibited by myelin, ex-et al., 2002; Yang et al., 1996). Of these, two, ganglio-
press the NgR (not shown). Although it has not yet beensides and the neurotrophin receptor p75 (Vinson et al.,
demonstrated directly that NgR is indeed responsible2001; Yamashita et al., 2002; Vyas et al., 2002), have
for the effects of MAG on young neurons, it is possiblebeen suggested as functional MAG receptors involved
that depending on the intrinsic state of the neuron—highin inhibition. As MAG is a member of the Siglec family
or low cAMP—NgR can transduce either an inhibitoryof sialic acid binding proteins (Crocker et al., 1998; Kelm
signal or a signal that promotes growth.et al., 1994), it can bind specific gangliosides (as well
The results presented here, together with the findingsas sialic acid-bearing glycoproteins), most notably GT1b
of others (Fournier et al., 2001; Wang et al., 2002), showand GD1A (Collins et al., 1997). However, results pre-
that three distinct inhibitors in myelin each require ansented here are consistent with our previous conclusion
(Tang et al., 1997a) that sialic acid-dependent binding interaction with the NgR to exert their inhibitory effects.
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nant Nogo66 protein fused to AP was prepared as described beforeThis finding poses the NgR as a very attractive target
(Fournier et al., 2001; Wang et al., 2002).for developing therapies for spinal cord and CNS injury.
Precipitation AssaysExperimental Procedures
Cerebellar neurons, DRG neurons (PND4-7), CHO cells expressing
NgR-FLAG, or control CHO cells were lysed in 50 mM Tris-HClNeurite Outgrowth Assays
(pH 7.5) RIPA buffer (Amersham). After pre-clearing with protein AThe neurite outgrowth assay on MAG-expressing cells was carried
sepharose, the lysates were incubated with either MAG-Fc (20out as described previously (Cai et al., 1999; Mukhopadhyay et al.,
g/ml), MAG (d1-3)-Fc (20 g/ml), or an anti-flag antibody (1:1000,1994). Briefly, 5  104 isolated cerebellar or DRG neurons from
Santa Cruz) for 4 hr at 4C, after which 50 l of 50% protein AP4–P8 rat pups were plated onto confluent monolayers of control
sepharose beads was added and incubation continued for 60 minand MAG-expressing CHO cells in 8-chamber tissue culture slides
at 4C. The samples were centrifuged and the pellet washed twice(Lab-Tek). Where indicated, a polyclonal antibody to NgR (Santa
with lysis buffer. The proteins in the pellet were dissociated by theCruz) was included or NgR-AP, prepared as previously described,
addition of SDS sample buffer and boiling for 10 min before beingwas preincubated with the cells before the addition of neurons,
centrifuged and the proteins in the supernatant separated in a 10%at the concentrations indicated. After 16–18 hr of incubation, the
PAGE, prior to being transferred to PVDF membrane and stainedcultures were fixed for 30 min with 4% paraformaldehyde, perme-
for NgR.abilized with ice-cold methanol, and immunostained with a rabbit
polyclonal antibody against GAP43 (1:4000, from R. Curtis and G.
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